Skip to main content
OpenTrials
Completed

NCT Number: NCT03009357

Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis

The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyrotoxicosis Autoimmune Diseases Endocrine System Diseases Exophthalmos Eye Diseases Goiter Graves Disease Hyperthyroidism Immune System Diseases Orbital Diseases Thyroid Diseases Thyroiditis

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

About this study

Activity trackers to be used: Fitbit Charge HR (TM)

Data which ware provided by Fitbit app (TM) will be analyzed in this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing newly developed or recurrent thyrotoxicosis who are treated and followed-up in Seoul National University Bundang Hospital
  • Patients who can use wearable activity trackers and smartphone applications
  • In case of Graves' disease, patients who will treated by anti-thyroid drugs

Exclusion criteria

  • Patients who have thyrotoxic periodic paralysis
  • In case of Graves' disease, patients who will treated by radioactive iodine therapy or thyroidectomy
  • Patients who have thyrotoxicosis due to toxic nodular disease

Treatment and study plan

Primary outcomes

  1. Association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status

    Time frame: continuous monitoring through the study period (average 3 months)

Secondary outcomes

  1. Association between user-generated dietary parameters on mobile applications and the thyrotoxic status

    Time frame: continuous monitoring through the study period (average 3 months)

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Clinical Application of Continuous Monitoring Data for the Pulse Rate, Exercise, and Calorie Intake by Wearable Activity Trackers in the Patients With Thyrotoxicosis

Acronym: AT-thyro

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 4, 2017
Registry last updated
Apr 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.